Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...

In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

The Food and Drug Administration has approved a new drug that could prevent HIV infections with just two shots every year and ...

HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Gilead’s Yeztugo will offer an alternative to treatments such as daily pills and every-other-month injections.

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

In a bold step toward global health justice, Ugandan biotech company DEI BioPharma has announced it will begin manufacturing ...

A twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by ...

Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

“This is a historic day in the decades-long fight against HIV,” Gilead CEO Daniel O’Day said in the company’s announcement.

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...